{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T05:19:30Z","timestamp":1763356770385,"version":"3.45.0"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2025.1736682","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T05:16:59Z","timestamp":1763356619000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: Advances in targeted therapy and biomarker research for endocrine-related cancers, volume II"],"prefix":"10.3389","volume":"16","author":[{"given":"Mei","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanshuang","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-025-01031-9","article-title":"Endocrine-disrupting chemicals as prostate carcinogens","volume":"22","author":"Feij\u00f3","year":"2025","journal-title":"Nat Rev Urol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2020.11.012","article-title":"LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies","volume":"73","author":"Revilla","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17203342","article-title":"Epigenetic regulation of immune responses in endocrine-related cancers and its role in immunotherapy","volume":"17","author":"Akyuz","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1533623","article-title":"Editorial: Advances in targeted therapy and biomarker research for endocrine-related cancers","volume":"15","author":"Wu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0070","article-title":"Epigenetic alterations in endocrine-related cancer","volume":"21","author":"Rodr\u00edguez-Rodero","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231710086","article-title":"Hormone-glutamine metabolism: A critical regulatory axis in endocrine-related cancers","volume":"23","author":"Xu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.coph.2021.06.002","article-title":"Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers","volume":"60","author":"Le\u00f3n-Gonz\u00e1lez","year":"2021","journal-title":"Curr Opin Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adk0627","article-title":"Targeting PTPN2 enhances human CAR T cell efficacy and the development of long-term memory in mouse xenograft models","volume":"17","author":"Du","year":"2025","journal-title":"Sci Transl Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12022-025-09883-y","article-title":"High prevalence of potential molecular therapeutic targets in poorly differentiated thyroid carcinoma","volume":"36","author":"Zambelli","year":"2025","journal-title":"Endocr Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s44161-025-00712-3","article-title":"Cardiac adaptation to endurance exercise training requires suppression of GDF15 via PGC-1\u03b1","volume":"4","author":"Khetarpal","year":"2025","journal-title":"Nat Cardiovasc Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2025.102942","article-title":"Targeting pediatric adrenocortical carcinoma: Molecular insights and emerging therapeutic strategies","volume":"136","author":"Kuhlen","year":"2025","journal-title":"Cancer Treat Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00122-025-05077-6","article-title":"GWAS and gene co-expression network analysis reveal the genetic control of seed germination under salt stress in maize","volume":"138","author":"Zhang","year":"2025","journal-title":"Theor Appl Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1186\/s12864-025-12136-1","article-title":"Identification of key genes associated with overwintering in Histia rhodope larva using gene co-expression network analysis","volume":"26","author":"Yang","year":"2025","journal-title":"BMC Genomics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"9477","DOI":"10.1038\/s41467-025-65227-8","article-title":"DNA methylation patterns facilitate tracing the origin of neuroendocrine neoplasms","volume":"16","author":"Goeppert","year":"2025","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"102998","DOI":"10.1016\/j.ctrv.2025","article-title":"The importance of education and training in neuroendocrine neoplasms: challenges and opportunities for multidisciplinary management","volume":"139","author":"Panzuto","year":"2025","journal-title":"Cancer Treat Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.106357","article-title":"PROTAC-Surufatinib suppresses pancreatic neuroendocrine neoplasms progression by inducing ferroptosis through inhibiting WNT\/\u03b2-catenin pathway mediated by HMOX1","volume":"21","author":"Xue","year":"2025","journal-title":"Int J Biol Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1736682\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T05:17:00Z","timestamp":1763356620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1736682\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":16,"alternative-id":["10.3389\/fendo.2025.1736682"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1736682","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"article-number":"1736682"}}